{"id":4239,"date":"2025-07-10T13:57:26","date_gmt":"2025-07-10T10:57:26","guid":{"rendered":"https:\/\/pharmaworlddergi.com\/?p=4239"},"modified":"2025-07-10T14:02:24","modified_gmt":"2025-07-10T11:02:24","slug":"takeda-is-modelindeki-degisiklikler-ve-atamalar-ile-turkiyede-guclenmeye-devam-ediyor","status":"publish","type":"post","link":"https:\/\/pharmaworlddergi.com\/?p=4239","title":{"rendered":"Takeda, \u0130\u015f Modelindeki De\u011fi\u015fiklikler ve Atamalar \u0130le T\u00fcrkiye’de G\u00fc\u00e7lenmeye Devam Ediyor"},"content":{"rendered":"\n

Japon ila\u00e7 devi Takeda, T\u00fcrkiye operasyonundaki liderlik atamalar\u0131 ve i\u015f modelindeki yeniliklerle g\u00fcc\u00fcne g\u00fc\u00e7 kat\u0131yor.<\/strong><\/a><\/p>\n\n\n\n

Ger\u00e7ekle\u015fen atamalar ile Takeda T\u00fcrkiye\u2019de Nadir Genetik Hastal\u0131klar ve Onkoloji \u0130\u015f Birimi Direkt\u00f6rl\u00fc\u011f\u00fc G\u00f6zde Uzuner, Plazma T\u00fcrevli Tedaviler \u0130\u015f Birimi Direkt\u00f6rl\u00fc\u011f\u00fc \u00d6mer Pek\u015fen, Medikal ve Hasta Hizmetleri Direkt\u00f6rl\u00fc\u011f\u00fc ise Dr. Mahir Kula taraf\u0131ndan y\u00f6netilecek.<\/strong><\/p>\n\n\n\n

\u201cDaha sa\u011fl\u0131kl\u0131, daha parlak bir gelecek\u201d vizyonuyla tedaviler geli\u015ftiren Takeda, 244 y\u0131ll\u0131k k\u00f6kl\u00fc ge\u00e7mi\u015fiyle 80 \u00fclkede Nadir Genetik Hastal\u0131klar, Onkoloji, Hematoloji, Gastroenteroloji, \u0130mm\u00fcnoloji, N\u00f6robilim, Plazma T\u00fcrevi Tedaviler ve A\u015f\u0131alanlar\u0131nda \u00e7al\u0131\u015fmalar y\u00fcr\u00fctmektedir. <\/p>\n\n\n

\n
\"\"<\/figure><\/div>\n\n\n

Takeda T\u00fcrkiye Genel M\u00fcd\u00fcr\u00fc Nura Aykanat<\/strong><\/p>\n\n\n\n

\u201cT\u00fcrkiye\u2019deki i\u015f modelimizi, g\u00fcncellenen global stratejimizle paralel bir \u015fekilde yeniden olu\u015fturuyoruz. Yapt\u0131\u011f\u0131m\u0131z de\u011fi\u015fiklikler ile \u00e7evik, dinamik ve maksimum payda\u015f odakl\u0131 bir operasyon hedefliyoruz. Bu \u00e7er\u00e7evede, temmuz ay\u0131nda s\u00fcrd\u00fcr\u00fclebilir b\u00fcy\u00fcmeyi desteklemek i\u00e7in liderlik ekibinde 3 atama ger\u00e7ekle\u015ftirdik. Farkl\u0131 yetkinlikleri ve \u00e7ok y\u00f6nl\u00fc bak\u0131\u015f a\u00e7\u0131lar\u0131yla aram\u0131za kat\u0131lan yeni liderlerimizin, kurumumuzun stratejik hedeflerine ve s\u00fcrd\u00fcr\u00fclebilir ba\u015far\u0131s\u0131na katk\u0131lar sunaca\u011f\u0131na inan\u0131yorum.\u201d<\/em><\/strong> dedi.<\/p>\n\n\n\n

Takeda T\u00fcrkiye<\/strong> Nadir Genetik Hastal\u0131klar ve Onkoloji \u0130\u015f Birimi Direkt\u00f6r\u00fc G\u00f6zde Uzuner<\/strong><\/p>\n\n\n

\n
\"\"<\/figure><\/div>\n\n\n

G\u00f6zde Uzuner, FMCG ve ila\u00e7 end\u00fcstrilerindeki 15 y\u0131ll\u0131k profesyonel deneyimi s\u00fcresince yerel ve uluslararas\u0131 d\u00fczeylerde \u00f6nemli sorumluluklar \u00fcstlendi. Takeda\u2019da K\u0131demli \u00dcr\u00fcn M\u00fcd\u00fcr\u00fc, Sat\u0131\u015f – Pazarlama M\u00fcd\u00fcr\u00fc ve ICMEA B\u00f6lgesi Ticari Uzman\u0131 gibi farkl\u0131 pozisyonlarda \u00e7al\u0131\u015ft\u0131\u011f\u0131 5 y\u0131l\u0131 a\u015fk\u0131n s\u00fcrede \u00fcr\u00fcn lansmanlar\u0131na liderlik eden ve global d\u00fczeyde bir\u00e7ok \u00f6d\u00fcl ile takdir edilen Uzuner; g\u00f6rev s\u00fcresi boyunca fonksiyonlar aras\u0131 i\u015f birlikleri ve i\u015f d\u00f6n\u00fc\u015f\u00fcm projelerinde de etkin rol oynad\u0131. Takeda\u2019ya yeniden kat\u0131lmadan \u00f6nce Novo Nordisk\u2019te Uluslararas\u0131 Operasyonlar Strateji Ofisi b\u00fcnyesinde Obezite Pazar Geli\u015ftirme Lideri olarak g\u00f6rev yapt\u0131. Stratejik bak\u0131\u015f a\u00e7\u0131s\u0131, payda\u015f y\u00f6netimi konusundaki uzmanl\u0131\u011f\u0131 ve de\u011fer odakl\u0131 yakla\u015f\u0131m\u0131yla Nadir Genetik Hastal\u0131klar ve Onkoloji \u0130\u015f Birimi\u2019ne liderlik edecek olan Uzuner, Bo\u011fazi\u00e7i \u00dcniversitesi Ekonomi B\u00f6l\u00fcm\u00fc\u2019nden 2010 y\u0131l\u0131nda mezun olmu\u015f ve 2012 y\u0131l\u0131nda Galatasaray \u00dcniversitesi\u2019nde MBA e\u011fitimini tamamlam\u0131\u015ft\u0131r.<\/p>\n\n\n\n

Takeda T\u00fcrkiye Plazma T\u00fcrevli Tedaviler \u0130\u015f Birimi Direkt\u00f6r\u00fc \u00d6mer Pek\u015fen<\/strong><\/p>\n\n\n

\n
\"\"<\/figure><\/div>\n\n\n

\u00d6mer Pek\u015fen, Takeda\u2019da g\u00f6rev ald\u0131\u011f\u0131 12 y\u0131l\u0131 a\u015fk\u0131n s\u00fcre boyunca \u00e7e\u015fitli pozisyonlarda fark yaratan projelerde yer ald\u0131. Takeda’n\u0131n Shire’\u0131 sat\u0131n almas\u0131n\u0131n ard\u0131ndan kurum b\u00fcnyesindeki sorumluluklar\u0131n\u0131 ba\u015far\u0131yla hayata ge\u00e7iren Pek\u015fen, Takeda\u2019daki kariyeri boyunca Singapur\u2019da Geli\u015fen ve B\u00fcy\u00fcyen Pazarlar (GEM) B\u00f6lgesi Ticari Strateji Direkt\u00f6rl\u00fc\u011f\u00fc ve Plazma Kaynakl\u0131 Tedaviler Marka M\u00fcd\u00fcrl\u00fc\u011f\u00fc g\u00f6revlerini \u00fcstlendi. GEM B\u00f6lgesi\u2019ndeki mevcut \u201cTicari Strateji Direkt\u00f6r\u00fc\u201d rol\u00fcnde, GEM Liderlik Ekibi\u2019nin stratejik i\u015f orta\u011f\u0131 olarak 20\u2019den fazla \u00f6ncelikli pazarda, 10\u2019dan fazla lansman ve b\u00fcy\u00fcme alan\u0131nda ticari strateji ve operasyonlar\u0131n\u0131 ba\u015far\u0131yla y\u00f6netti. Gelece\u011fe y\u00f6n veren vizyonu, ekipleriyle kurdu\u011fu g\u00fc\u00e7l\u00fc i\u015f birlikleri ve hasta odakl\u0131 yakla\u015f\u0131m\u0131yla Pek\u015fen, Takeda\u2019n\u0131n b\u00f6lgesel b\u00fcy\u00fcme hedeflerine \u00f6nemli katk\u0131larda bulundu. Liderlik etti\u011fi projeler, yaln\u0131zca i\u015f sonu\u00e7lar\u0131na de\u011fil, ayn\u0131 zamanda organizasyonel k\u00fclt\u00fcre de s\u00fcrd\u00fcr\u00fclebilir de\u011fer katt\u0131. Ger\u00e7ekle\u015ftirdi\u011fi ba\u015far\u0131l\u0131 projeleri ile global ve b\u00f6lgesel \u00f6d\u00fcller alan \u00d6mer Pek\u015fen; End\u00fcstri M\u00fchendisli\u011fi lisans e\u011fitimini \u0130stanbul Teknik \u00dcniversitesi’nde, y\u00fcksek lisans\u0131n\u0131 ise Bo\u011fazi\u00e7i \u00dcniversitesi’nde tamamlam\u0131\u015ft\u0131r.<\/a><\/p>\n\n\n\n

Takeda T\u00fcrkiye Medikal ve Hasta Hizmetleri Direkt\u00f6r\u00fc Dr. Mahir Kula<\/strong><\/p>\n\n\n

\n
\"\"<\/figure><\/div>\n\n\n

\u0130la\u00e7 End\u00fcstrisinde 13 y\u0131l\u0131 a\u015fk\u0131n deneyime sahip olan Dr. Mahir Kula; Roche, Baxalta ve Baxter gibi global \u015firketlerde \u00fcstlendi\u011fi medikal ve ticari liderlik rollerinde ba\u015far\u0131l\u0131 \u00e7al\u0131\u015fmalara imza att\u0131. Hematoloji, Onkoloji, \u0130mm\u00fcnoloji, N\u00f6robilim ve Oftalmoloji gibi tedavi alanlar\u0131nda bilimsel yakla\u015f\u0131m\u0131, stratejik \u00f6ng\u00f6r\u00fcs\u00fc ve ekip liderli\u011fiyle kurumlar\u0131n medikal vizyonuna y\u00f6n veren g\u00fc\u00e7l\u00fc bir liderlik sergiledi. Takeda T\u00fcrkiye Medikal Direkt\u00f6r\u00fc olarak g\u00f6revine ba\u015flayan Kula; \u015firketin medikal stratejilerinin geli\u015ftirilmesi ve uygulanmas\u0131na liderlik edecek, bilimsel \u00e7al\u0131\u015fmalara, saha ekiplerinin geli\u015fimine ve hasta odakl\u0131 yakla\u015f\u0131mlar\u0131n yayg\u0131nla\u015ft\u0131r\u0131lmas\u0131na katk\u0131 sa\u011flayacakt\u0131r. T\u0131p e\u011fitimini Akdeniz \u00dcniversitesi T\u0131p Fak\u00fcltesi\u2019nde tamamlayan Mahir Kula, Klinik Farmakoloji alan\u0131ndaki uzmanl\u0131\u011f\u0131n\u0131 \u0130stanbul \u00dcniversitesi Cerrahpa\u015fa T\u0131p Fak\u00fcltesi\u2019nde yapt\u0131. Bilimsel formasyonunu, sosyal ve teknolojik boyutlarda da derinle\u015ftiren Kula; \u0130stanbul \u00dcniversitesi\u2019nde Sosyoloji Lisans Program\u0131na ve Gazi \u00dcniversitesi\u2019nde Sa\u011fl\u0131k Bili\u015fimi Y\u00fcksek Lisans Program\u0131na devam etmektedir. Kula, bu \u00e7ok y\u00f6nl\u00fc akademik ge\u00e7mi\u015fi ile sa\u011fl\u0131k enformati\u011fi, dijital sa\u011fl\u0131k, ger\u00e7ek ya\u015fam verisi \u00fcretimi ve hasta hizmetleri gibi stratejik alanlara uzmanl\u0131\u011f\u0131n\u0131 yans\u0131tacakt\u0131r.<\/p>\n","protected":false},"excerpt":{"rendered":"

Japon ila\u00e7 devi Takeda, T\u00fcrkiye operasyonundaki liderlik atamalar\u0131 ve i\u015f modelindeki yeniliklerle g\u00fcc\u00fcne g\u00fc\u00e7 kat\u0131yor.<\/p>\n

Ger\u00e7ekle\u015fen atamalar ile Takeda T\u00fcrkiye\u2019de Nadir Genetik Hastal\u0131klar ve Onkoloji \u0130\u015f Birimi Direkt\u00f6rl\u00fc\u011f\u00fc G\u00f6zde Uzuner, Plazma T\u00fcrevli Tedaviler \u0130\u015f Birimi Direkt\u00f6rl\u00fc\u011f\u00fc \u00d6mer Pek\u015fen, Medikal ve Hasta Hizmetleri Direkt\u00f6rl\u00fc\u011f\u00fc ise Dr. Mahir Kula taraf\u0131ndan y\u00f6netilecek.<\/p>\n","protected":false},"author":1,"featured_media":4252,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[48,44],"tags":[],"_links":{"self":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/4239"}],"collection":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4239"}],"version-history":[{"count":3,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/4239\/revisions"}],"predecessor-version":[{"id":4254,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/posts\/4239\/revisions\/4254"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=\/wp\/v2\/media\/4252"}],"wp:attachment":[{"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4239"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4239"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharmaworlddergi.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4239"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}